Concord Medical’s major shareholder boosts stake

Published 13/05/2025, 11:14
Concord Medical’s major shareholder boosts stake

Concord Medical (TASE:BLWV) Services Holdings Limited (NYSE:CCM), a healthcare provider specializing in cancer care, imaging diagnosis, and research and development in China, has disclosed through a Form 6-K filing with the U.S. Securities and Exchange Commission that its subsidiary, Shanghai Medstar, has increased its shareholding in Concord Healthcare Group Co., Ltd. The transaction occurred on Monday, involving the purchase of 95,400 H shares on the open market, which equates to approximately 0.01% of Concord Healthcare’s total issued shares as of the announcement date.

This latest acquisition follows a similar purchase by Shanghai Medstar on May 7, 2025. Concord Healthcare, a part of Concord Medical Services Holdings and listed on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code 2453.HK, has seen its shares traded actively since its listing on January 9, 2024.

Investors and interested parties can access transaction details related to Concord Healthcare on the Hong Kong Stock Exchange’s website. The 6-K form serves as a report of foreign private issuers to the SEC and provides monthly updates on significant corporate events.

The filing was signed by Jianyu Yang, Chairman and Chief Executive Officer of Concord Medical Services Holdings Limited, on behalf of the registrant, as required by the Securities Exchange Act of 1934. The document confirms the company’s commitment to transparency and regulatory compliance in its financial reporting.

This information, based on the company’s latest SEC filing, indicates an ongoing interest by the controlling shareholder to increase its stake in Concord Healthcare. As the market processes this news, shareholders and analysts will be watching the company’s stock performance on the NYSE and HKSE closely.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.